Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
DNA SEQ
AddedFeb 16, 2024
UpdatedJun 18, 2026
DNA SEQ

DNA SEQ

DNA SEQ: Leveraging AI and crystallography for genomic profiling, we match cancer patients' genomics with targeted therapies.

HQ
Los Angeles, CA, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

DNA SEQ leverages AI and crystallography to provide genomic profiling services that match cancer patients' genomic profiles with targeted therapies. Utilizing a unique crystallography-based filtering methodology and a proprietary crystal structures library, DNA SEQ's machine learning algorithm offers predictive personalized medicine. This approach aids physicians in making informed treatment decisions for oncology patients, enhancing the precision of targeted cancer therapies.

DNA SEQ has developed a significant technological alliance, integrating structural genomics with advanced machine learning. Their innovative methodology has positioned them as a key player in the field of personalized oncology treatment. By focusing on matching specific genomic profiles with available targeted drugs, DNA SEQ has made substantial strides in improving patient outcomes and advancing the field of precision medicine.

DNA SEQ - Similar Companies

Quantgene logo

Quantgene

quantgene.com

Data Driven Bioscience logo

Data Driven Bioscience

Sequencing.com logo

Sequencing.com

sequencing.com

Clear Gene logo

Clear Gene

cleargene.com

GenomOncology logo

GenomOncology

genomoncology.com

Oncobox logo

Oncobox

oncobox.com

Genomate Health logo

Genomate Health

genomate.health

Liquid Genomics logo

Liquid Genomics

MyCancerDB logo

MyCancerDB

ennov1.com

Genomenon logo

Genomenon

genomenon.com

Sequegenics logo

Sequegenics

sequegenics.com

D2G Oncology logo

D2G Oncology

d2g-oncology.com

Sequence Bio logo

Sequence Bio

sequencebio.com

DNA Guide logo

DNA Guide

Cureseq logo

Cureseq

cureseq.com

DNA SEQ - Quick Facts

Who are DNA SEQ's competitors?

Companies similar to DNA SEQ include Quantgene, Data Driven Bioscience, Sequencing.com and Clear Gene.

When was DNA SEQ founded?

DNA SEQ was founded in 2013.

Where is DNA SEQ's headquarters located?

DNA SEQ's headquarters is located in Los Angeles, CA, US.

When was DNA SEQ's last funding round?

DNA SEQ's most recent funding round was for $1M (USD) in May 2013.

How much has DNA SEQ raised to-date?

As of May 24, 2013, DNA SEQ has raised a total of $1M (USD).

How many employees does DNA SEQ have?

DNA SEQ has 6 employees as of Feb 4, 2024.

DNA SEQ - Classification

Ownership
  • Private
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Genomic Profiling
Tags
  • Biotech
  • Data
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 9 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified